Norman Kane, MD
Orthopaedic Surgery · Carlsbad, CANPI 1588625982
Payments from drug & device makers
What this record shows
This record is dominated by other: $342,239 of the $343,837 with a category attached, or 99.5%. Encore Medical, LP accounts for 99.5% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $342,264 and has fallen 99.8% since, to $821 in 2025. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $7640.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$342K
- Stryker$821
- Johnson & Johnson$289
- Bioventus LLC$110
- Illuminoss Medical, Inc.$105
- Arthrosurface Incorporated$52
- plus $220 from 10 others
What the payments were for
- Food & beverage$1,0290%
- Education$5690%
- Other$342,239100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 1 | $342,239 |
| Stryker(2 entities) | 7 | $821 |
| Johnson & Johnson(2 entities) | 16 | $289 |
| Bioventus LLC | 6 | $110 |
| Illuminoss Medical, Inc. | 3 | $105 |
| Arthrosurface Incorporated | 2 | $52 |
| Bsn Medical Inc | 1 | $39 |
| Heron Therapeutics, Inc. | 1 | $25 |
| Heraeus Medical, LLC. | 1 | $23 |
| Pacira Therapeutics, Inc. | 1 | $23 |
| Nevro Corp. | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $20 |
| ERMI LLC | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Biotissue Holdings Inc. | 1 | $16 |
| Acell, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACCOLADE$569
How this compares
$343,837 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 104 | $744 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $337 |
| Meloxicam | 61 | $240 |
| Tramadol Hcl | 70 | $134 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Carlsbad
- Bradford HackArcadia$18.3M
- Robert GorabOrange$13.6M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Peter NewtonSan Diego$4.2M
- Sigurd BervenSan Francisco$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.